Back to search results

Agenda-Setting for Advanced Kidney Disease Trial

This study is testing a new tool called "CKD Topics" to help people with advanced chronic kidney disease (CKD) (stages 4-5) and their care partners talk with their doctors. CKD Topics is a list of discussion topics designed to improve conversations during clinic visits, especially for those in rural areas. Researchers want to see if using CKD Topics is practical and helpful compared to usual care. You could join if you are an adult over 18 with advanced CKD, or a care partner, clinician, or staff supporting these patients, are English-speaking, and attend outpatient visits. The study aims to enroll 108 participants and will measure how feasible (practical) it is to use CKD Topics over 16 months.

Study design
This is a stepped-wedge randomized clinical trial, meaning all participants will eventually experience both usual care and the CKD Topics tool, but at different times. The study involves patients, care partners, and clinicians.
What's involved
You would use the CKD Topics tool during your clinic visits for a period of time, after an initial period of usual care. The study will last for 16 months from your enrollment.
Compensation
Not stated in the trial record.
Follow-up
Your participation will be measured from enrollment to the end of treatment at 16 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07024953

The Agenda-Setting for Kidney Disease Trial

Not Yet Recruiting
NAAges 18+InterventionalHealth services
Dartmouth-Hitchcock Medical Center
~108 participants
Updated 2025-06-24 on ClinicalTrials.gov
What's tested:Chronic Kidney Disease Structured Agenda-Setting Tool

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Primary Feasibility Outcome
Measured over From enrollment to the end of treatment at 16 months

Conditions

Chronic Kidney Disease Stage 4
Chronic Kidney Disease Stage 5

Explore related trials

Chronic Kidney Disease

NCT07024953

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshireno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Catherine H. Saunders, Assistant Professor of Medicine and of Health Policy, PhD, MPH
[email protected]
603-653-3436
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults \>18 years old who have been diagnosed with advanced CKD (stages 4-5).
Care partners, clinicians and staff supporting these CKD patients who are willing and able to provide informed consent
English-speaking
Able to provide informed consent
Patient must be attending outpatient visits \*(in-person and/or telehealth allowable).

Exclusion

Children under 18 years old will not be included
Non-English-speaking patients and/or care partners
Patients on dialysis
Individuals unable or unwilling to provide informed consent

What this trial measures

  • Primary Feasibility OutcomeFrom enrollment to the end of treatment at 16 months

    The primary outcome will be feasibility, assessed by the proportion of patients who received the intervention.